OBJECTIVE: To evaluate the safety and efficacy of combined revascularisation in paediatric patients with moyamoya disease (MMD). METHODS: A retrospective analysis was conducted on 86 paediatric patients who underwent combined revascularisation at the Department of Neurosurgery of Aviation General Hospital between May 2016 and June 2022. Clinical data, surgical techniques, postoperative complications, and follow-up outcomes were analysed. RESULTS: < 0.05). CONCLUSION: Combined revascularisation is a safe and effective treatment for paediatric MMD, with favourable long-term outcomes.
Tang et al. (Tue,) studied this question.